Australia markets closed

BCAL Diagnostics Limited (BDX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.1000-0.0050 (-4.76%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 25.23M
Enterprise value 21.71M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)4.16
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.21

Trading information

Stock price history

Beta (5Y monthly) 0.27
52-week change 333.33%
S&P500 52-week change 321.23%
52-week high 30.2100
52-week low 30.0700
50-day moving average 30.0939
200-day moving average 30.0999

Share statistics

Avg vol (3-month) 3215.9k
Avg vol (10-day) 3342.28k
Shares outstanding 5252.3M
Implied shares outstanding 6252.3M
Float 897.45M
% held by insiders 153.87%
% held by institutions 14.97%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -134.82%
Operating margin (ttm)-119.11%

Management effectiveness

Return on assets (ttm)-34.87%
Return on equity (ttm)-73.51%

Income statement

Revenue (ttm)3.71M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)84.80%
Gross profit (ttm)N/A
EBITDA -4.25M
Net income avi to common (ttm)-5M
Diluted EPS (ttm)-0.0200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.02M
Total cash per share (mrq)0.02
Total debt (mrq)1.5M
Total debt/equity (mrq)24.77%
Current ratio (mrq)5.21
Book value per share (mrq)0.02

Cash flow statement

Operating cash flow (ttm)-4.21M
Levered free cash flow (ttm)-2.51M